Sex differences in outcomes of total hip arthroplasty for the treatment of ankylosing spondylitis
- PMID: 34653077
- PMCID: PMC8577654
- DOI: 10.1097/CM9.0000000000001782
Sex differences in outcomes of total hip arthroplasty for the treatment of ankylosing spondylitis
Conflict of interest statement
None.
References
-
- Rocha FAC, Pinto ACMD, Lopes JR, Deodhar A. Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature. Clin Rheumatol 2021; 40:1881–1887. doi: 10.1007/s10067-020-05519-0. - PubMed
-
- Huang F, Sun F, Wan WG, Wu LJ, Dong LL, Zhang X, et al. . Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, phase III China-centric study, MEASURE 5. Chin Med J 2020; 133:2521–2531. doi: 10.1097/CM9.0000000000001099. - PMC - PubMed
-
- Zhang L, Yang D, Yin X, Zhou Y. Risk factors for poor hip flexion after total hip arthroplasty for the treatment of ankylosing spondylitis a multivariate analysis. Clin Rheumatol 2014; 33:1295–1301. doi: 10.1007/s10067-014-2575-5. - PubMed
-
- Gautam D, Malhotra R. Total hip arthroplasty in ankylosing spondylitis with extension contracture of hips. J Arthroplasty 2019; 34:71–76. doi: 10.1016/j.arth.2018.08.025. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
